ENTITY

Genfleet Therapeutics (2595 HK)

38
Analysis
Health Care • China
Genfleet Therapeutics is a biopharmaceutical company focused on developing innovative treatments for oncology, including various solid tumors, and autoimmune and inflammatory diseases. The company's pipeline includes products like GFH925 (fulzerasib) for advanced non-small cell lung cancer and GFH375, a KRAS G12C inhibitor. Genfleet Therapeutics was incorporated in 2017 and is headquartered in Shanghai, China.
more
Company Event • 25 Mar 2027 17:00 • Upcoming
Add To Calendar

H2 2026

Company Event • 15 Sep 2026 16:00 • Upcoming
Add To Calendar

Study result presentation

Company Event • 14 Sep 2026 16:00 • Upcoming
Add To Calendar

2026 World Conference on Lung Cancer presentation

Company Event • 22 Aug 2026 16:00 • Upcoming
Add To Calendar

H1 2026

Company Event • 02 Jun 2026 16:00 • Upcoming
Add To Calendar

Study result presentation

x